LEARN ABOUT MRI

MRI for Cancer Detection in the Brain

Magnetic Resonance Imaging (MRI) is a noninvasive and painless medical imaging technique used for diagnosing many medical conditions. In this article, we explore how MRI is used for detecting brain cancers, its benefits, and what to expect.

Introduction

Magnetic Resonance Imaging (MRI) is a non-invasive, radiation-free imaging technique that uses powerful magnets, such as those in a 3-Tesla scanner, to generate detailed images of the brain’s structure and blood vessels. MRI plays a crucial role in the early detection of brain tumours, including glioblastoma, meningioma, and brain metastasis, which collectively account for a substantial portion of primary and secondary brain cancers. 

Early identification is critical: brain tumours affect over 300,000 people worldwide annually, and early-stage detection significantly improves treatment outcomes and survival rates1. Compared to other imaging methods, MRI offers superior sensitivity for identifying even small or subtle lesions, enabling clinicians to detect changes before symptoms arise2. This makes MRI an essential tool in the timely detection and management of brain abnormalities.

Learn more about MRI for cancer detection here.

Why You Might Need a Brain (Head) MRI

You may need a brain (head) MRI for several key reasons, especially when early detection can change outcomes:

  • New symptoms: These can manifest as sudden seizures, one-sided weakness, or a worsening, persistent headache3. An MRI can precisely identify lesion size, midline shift, or hidden bleeding, which are often missed on other scans.
  • Clarifying uncertain CT findings: While CT scans are rapid and good for detecting acute bleeds, MRI provides superior detail, distinguishing between conditions like glioblastoma and abscess by revealing necrotic cores or diffusion restriction4
  • Screening high-risk individuals: Those with a strong family history, inherited syndromes (e.g., neurofibromatosis type 1), or cancers prone to brain metastasis (such as melanoma or kidney cancer) may benefit from MRI for early tumour detection5.
  • Monitoring known lesions: MRI is essential for tracking the growth of tumours, such as meningiomas, or detecting regrowth in treated tumours by assessing features like perfusion (rCBV)6,7.
  • Pre-surgical mapping: Advanced MRI techniques, such as diffusion tensor imaging (DTI) and functional MRI (fMRI), map critical speech and motor tracts, guiding neurosurgeons to minimise functional loss during tumour removal8.
  • Second opinion for unexplained symptoms: Persistent dizziness or cognitive changes with normal other tests can prompt an MRI, where sequences like T1, T2, and FLAIR reveal subtle oedema or lesions often missed otherwise9.

You can use our Know Your Risk Calculator to understand your risk of cancer in just five minutes.

How To Prepare For Your Brain MRI

Here are a few tips to help you prepare for your MRI10:

  • Take your usual medications and eat normally, unless instructed to fast for sedation or contrast. Avoid heavy caffeine intake and stay hydrated.
  • Inform staff about any metal implants or devices, and bring safety cards for “MR-Conditional” implants, such as pacemakers or aneurysm clips.
  • Remove all metal items, including jewelry, hairpins, dental plates, and transdermal patches with foil, to prevent image distortion.
  • Bring your referral, prior brain images, and insurance pre-authorization to avoid delays.
  • Wear comfortable, metal-free clothing; ask about earplugs, music, or mirror goggles if you’re claustrophobic.
  • If contrast is planned, fast for 4–6 hours prior to the procedure. Inform staff about any kidney issues or past reactions to contrast agents, as safer alternatives may be available.
  • Arrange an escort home if you need sedation for claustrophobia.

You can read more about preparation for Ezra’s Full Body Scan here.

What Happens During a Brain Scan?

Upon arrival for your MRI, you will need to check in and complete a screening form. This will allow you to confirm the presence of implants, allergies, and whether you might need any anxiety medication.

During the scan, you will lie down on a sliding table. A lightweight head coil will act like a helmet for clear 3-Tesla images. Your head will be nestled in a small cushion that will keep you still. The scan typically lasts 30-45 minutes of actual “table time”, during which the technician may acquire multiple sequences (settings) (T1, T2, FLAIR, DWI, SWI, and sometimes perfusion or spectroscopy)11. Expect loud knocking noises (up to 110 dB); earplugs or headphones are provided to reduce discomfort. It’s normal to feel mild table vibrations.

You’ll stay in touch with the team via a two-way intercom and a squeeze bulb, allowing you to communicate or pause the scan if needed. If contrast is required, it’s injected halfway through, possibly causing a brief cool sensation. After the final sequence, the head coil is removed, and you’re free to go. 

At Ezra our Full Body Plus scan takes around 60 minutes total, with 45 minutes of table time. Earplugs or headphones are available.

After the scan, you will be contacted by a medical provider working with Ezra within roughly a week. On the day of the appointment, you will receive a copy of your report and access to your scanned images through the online portal.

MRI Safety, Risks & Side Effects

MRI is generally considered very safe when proper screening and protocols are followed, but certain risks and side effects should be understood:

  • Metal and implants: The strong 3-Tesla magnet can pull or heat older pacemakers, aneurysm clips, or metal fragments12. Most modern “MR-Conditional” devices (like cochlear implants or pain pumps) are safe after screening, but all implants must be checked before scanning13.
  • Gadolinium contrast: Macrocyclic gadolinium agents (e.g., gadobutrol) have an extremely low risk of allergic reactions or nephrogenic systemic fibrosis (NSF) when kidneys are healthy14. However, gadolinium can accumulate in tissues, and rare side effects such as headaches or skin changes have been reported. Many centres now offer contrast-free alternatives for routine follow-up15. You can read more about gadolinium contrast side effects here.
  • Incidental findings: About 4% of brain MRIs reveal unexpected abnormalities, such as small meningiomas or pituitary microadenomas, most of which require only monitoring rather than intervention16.
  • Claustrophobia: Anxiety inside the scanner is common. Wide-bore scanners, music, mirror goggles, or a single dose of oral sedative can help alleviate symptoms. Open MRI is an option if image detail can be sacrificed.
  • Zero Ionising Radiation: MRI uses magnetic fields and radio waves, not X-rays, so there is no ionising radiation exposure, making it safer for repeated scans compared to CT scans17.
  • Minor Sensations: Expect loud knocking, mild table vibration, and a brief cool flush if contrast is injected. Rare side effects include headaches, fatigue, or mild skin heating.

A deeper dive into possible side effects (such as heat, headaches, and gadolinium deposition) is available in our full guide.

At Ezra, we employ a contrast-free approach using wide-bore T3 machines to deliver a comfortable scanning experience.

Terms You Might See in Your MRI Report (And What They Mean)

There are a number of terms you might see in your MRI report after your brain scan. Here are some explanations for some common ones: 

Ring-enhancing lesion: A ring-enhancing lesion appears as a bright rim surrounding a darker centre after contrast dye is administered during an MRI or CT scan18. The ring is due to contrast uptake at the edge of the lesion, often raising concern for aggressive or infectious processes.

Diffusion restriction: This term refers to areas where the movement of water molecules is blocked or restricted, as detected by DWI or MRI19. Diffusion restriction is typical of tissues with high cellularity, such as lymphoma.

rCBV (relative cerebral blood volume): rCBV is a perfusion MRI measurement indicating the amount of blood volume in a given region of brain tissue. High rCBV values suggest increased blood supply, which is often seen in high-grade tumours due to the formation of new blood vessels20.

FLAIR hyperintensity: FLAIR (Fluid-Attenuated Inversion Recovery) is an MRI sequence that highlights abnormal fluid in the brain21. It is commonly used to detect regions of abnormality, such as those caused by tumours, stroke, or inflammation.

Dural tail: This is a tapered enhancement on the brain lining, which is typical of meningioma, seen in 60-72 per cent of cases22.

Calcifications: Calcifications are deposits of calcium within the brain tissue, which can be detected on MRI23. These are common in tumours like oligodendrogliomas.

Butterfly lesion: A butterfly lesion refers to a mass that crosses the midline of the brain through the corpus callosum, giving it a butterfly appearance on imaging24. This is common in glioblastomas.

Cho/NAA ratio: This is a chemical ratio measured by MR spectroscopy, comparing choline to N-acetylaspartate (a marker of healthy neurons)25. A Cho/NAA ratio >2-3 is suggestive of malignancy, as tumours tend to have increased choline and decreased NAA.

Ezra provides a radiologist-reviewed report in a non-technical and easy-to-understand format on your dashboard.

After the MRI Scan

After the MRI scan, you will be free to go home and continue with your day without any precautions26. If you received a sedative, you will need another person to pick you up. You will also not be able to drive, consume alcohol or operate heavy machinery 24 hours after the sedative. 

A team of experts will review your results and determine whether a follow-up is necessary and recommend the appropriate treatment if needed. If abnormalities are found, you may undergo ongoing monitoring every 2-3 months to track recurrence. You can receive support in the form of counselling and advice on how to handle aspects like claustrophobia

If you have a scan with us here at Ezra, you will receive your report within five to seven days and have the option to discuss it with a medical practitioner. You can also access your scan images through the online portal.

What MRI Can Show About Brain Cancer

MRI offers a detailed and comprehensive view of brain cancer, providing essential information for diagnosis and treatment planning. One of the key strengths of MRI is its ability to precisely pinpoint the location of a tumour, whether it’s in a specific lobe, deep brain nucleus, brainstem, or the meninges (the brain’s lining)27. This level of detail enables clinicians to identify the exact structures involved and plan the most effective intervention approach.

Different MRI sequences reveal the tumour’s internal makeup:

  • T1-weighted images show fat, blood, and necrosis28.
  • T2 and FLAIR images highlight fluid, oedema, and tumour infiltration; most tumours appear bright on T2/FLAIR due to high water content29.
  • Ring enhancement after contrast (gadolinium) administration can suggest aggressive tumours like glioblastoma or metastases30.
  • Susceptibility-weighted imaging (SWI) can detect microbleeds or calcifications within the tumour31

Certain imaging types can also show how active a tumour is. DWI assesses the movement of water molecules within brain tissue32. Tumours with restricted diffusion, appearing bright on DWI, are typically highly cellular, such as lymphomas or high-grade gliomas33. DWI is valuable for distinguishing between tumour types and grades, as well as for monitoring response to therapy34. Perfusion MRI, which measures blood flow within the tumour, provides additional information: a high rCBV is often seen in fast-growing, aggressive tumours35.

MRI is also essential for assessing the impact of a tumour on nearby brain structures. It effectively maps oedema, which appears as a high signal on T2/FLAIR images and low on T136. The presence of oedema can worsen symptoms and may be a sign of tumour aggressiveness. Additionally, MRI can identify blocked cerebrospinal fluid (CSF) pathways, which can lead to hydrocephalus, a potentially life-threatening complication37

Ezra utilises DWI as part of our whole-body MRI scans and artificial intelligence (AI) to enhance MRI images and convert radiology reports into layman's term translations.

Types of Brain Tumours and How They Look on MRI

  • Glioblastoma typically presents as a large, aggressive mass that may cross the corpus callosum (a band of fibres that connect the left and right hemispheres), producing a characteristic “butterfly” shape38. On MRI, it often shows a dark necrotic core surrounded by a bright ring of contrast enhancement, significant surrounding oedema, and mass effect. Patchy or ring enhancement is common.
Figure 1: T1-weighted image of a human butterfly glioblastoma. Adapted from: Source. Image obtained under the Creative Commons License.
  • Primary CNS Lymphoma usually appears as a solid, vividly enhancing mass that is dark grey on T1 and the same or darker on T239. It shows strong enhancement after contrast and is notable for very restricted diffusion on SWI, reflecting its high cellularity. The crossing of the corpus callosum can also be observed.
  • Metastases from cancers such as melanoma or kidney cancer often manifest as multiple lesions. On MRI, they are typically the same or darker on T1, brighter on T2, and show bright enhancement. Some metastases, especially those of melanoma, may appear bright on T1 due to the presence of melanin or blood products. SWI may reveal tiny haemorrhages within these lesions40.
Figure 2: Shape change over time during radiotherapy. Brain metastases of a primary tumour located in the salivary gland. T1-weighted MRI with gadolinium contrast. Adapted from: Source. Image obtained under the Creative Commons License.
  • Meningioma is a tumour that grows from the layers of tissue covering and protecting the brain and spinal cord, just inside the skull. On an MRI scan, meningiomas typically appear as a well-defined mass situated on the surface of the brain, often attached broadly to the surrounding tissue41. They commonly show a bright appearance after contrast dye and sometimes display a streak of enhancement along the brain lining.
  • Oligodendroglioma is a type of brain tumour that usually starts in the frontal lobe. On scans, it often shows small areas of calcium, sometimes described as having a “chicken wire” pattern42. On MRI, these tumours usually appear brighter than normal brain on certain images and can look patchy or uneven43. They often sit near the surface of the brain, where the outer (cortical) and inner (subcortical) layers meet, and may show a mild to moderate increase in brightness after contrast dye is given.
  • Pilocytic astrocytomas are brain tumours most often found in children. On MRI scans, they typically appear as a fluid-filled cyst with a small, solid bump (known as a mural nodule) on its wall44. The cyst appears very bright on certain images, and the bump lights up when contrast dye is used. 
  • Mimics such as brain abscesses can resemble tumours, showing ring enhancement and strong diffusion restriction, while cavernomas appear as lesions with dark “blooming” on susceptibility sequences due to blood products45,46.

Ezra screens for over 500 conditions, including the brain.

Types of MRI Scans Used in Brain Cancer Detection

There are multiple types of MRI scans, all using different methods to give a better visualisation of the brain. 

  • Standard MRI (T1 and T2): Uses magnetic fields and radio waves to construct an image of the brain and its structures47.
  • FLAIR silences fluid making swelling easier to see48.
  • DWI/ADC flags densely packed tumour cells49.
  • Perfusion imaging measures tumour blood flow (rCBV and rCBF)50.
  • Magnetic Resonance Spectroscopy (MRS) shows chemical peaks, such as high choline, associated with a 2-hydroxyglutarate spike (indicating an IDH mutant glioma)51.
  • SWI highlights calcium and micro-bleeds.
  • Functional MRI (fMRI)/DTI imaging maps critical white-matter tracts and speech or movement areas before surgery52.

MRI vs. Other Imaging Tests for Brain Cancer Detection

Modality Strengths Limitations
MRI Top soft-tissue detail, no radiation. Longer, louder, costlier.
CT Fast for trauma and fresh bleeding. Uses X-rays, poorer tumour contrast.
PET-CT Shows tumour metabolism (FDG, FET). Lower detail, higher radiation.
X-ray Cheap baseline skull imaging. Can’t see brain tissue.
Intra-op Ultrasound Real-time usage in the operating room. Very limited outside surgery.

Cost

The cost of a brain MRI scan on average ranges from £249 to £184553. At Ezra, we offer a full-body MRI scan that covers up to 13 organs, including the brain. 

At Ezra, our full-body scan (which includes the head, neck, abdomen, and pelvis) is offered at a £1495 all-inclusive price, including a 45-minute follow-up review of your scan findings with a medical practitioner. We have a location in London, with further locations across the UK coming soon.

Frequently Asked Questions

Does a brain MRI include the neck?

A standard brain MRI may include the upper part of the neck (upper cervical spine), but a full neck scan requires a dedicated cervical spine MRI. 

Is an MRI better than a CT scan for the brain?

MRI provides greater detail and sensitivity for brain abnormalities, while CT is faster and better for emergencies or bone detail; the choice depends on the clinical situation.

Can MRI results be seen immediately?

MRI images are available immediately after the scan, but an official radiologist's report typically takes 1-2 weeks, unless it is an emergency.

Can dementia be detected on an MRI?

MRI cannot directly diagnose dementia, but it can reveal brain changes associated with different types of dementia, aiding in diagnosis. 

Can I drive home after a brain MRI?

You can drive home after a brain MRI unless you have received sedation, in which case you should not drive.

Key Takeaways

  • 3-Tesla brain MRI detects tiny tumours early, without radiation, often before symptoms appear. 
  • Rapid T1, T2, FLAIR, and DWI scans reveal small lesions, swelling, and ring-enhancing features of aggressive cancers.
  • Contrast is not always needed - DWI plus ASL perfusion can asses tumour blood flow for safe screening.
  • Ezra delivers results in 5-7 days, enabling earlier diagnosis and more treatment options.

Consider booking an Ezra Full Body MRI Scan, which screens for up to 13 types of cancer, offering peace of mind through early detection.

Our MRI scan is designed to help detect cancer early without harmful radiation.
Book Scan Icon
It's quick and easy to book
Schedule your scan online at one of our locations nationwide.
Complete Scan Icon
Medical questionnaire
Fill out a quick online form to let us know about your medical history.
Get Scanned
Get your Ezra Full Body MRI Scan — it takes as little as 30 minutes and screens for potential cancer in up to 13 organs and 500+ conditions.
Walk Icon
A bespoke medical report
Your images are reviewed by board certified radiologists and our Clinical Team will deliver your Ezra Report within 5-7 days.

References

1. Samman RR, Timraz JH, Mosalem Al-Nakhli A, et al. The Impact of Brain Tumors on Emotional and Behavioral Functioning. Cureus. 16(12):e75315. doi:10.7759/cureus.75315

2. Knipp SC, Matatko N, Schlamann M, et al. Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: relation to neurocognitive function. Eur J Cardiothorac Surg. 2005;28(1):88-96. doi:10.1016/j.ejcts.2005.02.043

3. Brain tumours. nhs.uk. October 17, 2017. Accessed July 1, 2025. https://www.nhs.uk/conditions/brain-tumours/

4. Irimia A, Maher AS, Rostowsky KA, et al. Brain Segmentation From Computed Tomography of Healthy Aging and Geriatric Concussion at Variable Spatial Resolutions. Front Neuroinform. 2019;13:9. doi:10.3389/fninf.2019.00009

5. Neugut AI, Sackstein P, Hillyer GC, et al. Magnetic Resonance Imaging‐Based Screening for Asymptomatic Brain Tumors: A Review. Oncologist. 2019;24(3):375-384. doi:10.1634/theoncologist.2018-0177

6. Beutler BD, Nguyen ET, Parker RA, et al. Metastatic meningioma: Case report of a WHO grade I meningioma with liver metastases and review of the literature. Radiology Case Reports. 2019;15(2):110. doi:10.1016/j.radcr.2019.10.027

7. Kleibeuker EA, Fokas E, Allen PD, et al. Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect. Oncotarget. 2016;7(47):76613. doi:10.18632/oncotarget.12814

8. Leone A, Carbone F, Spetzger U, et al. Preoperative mapping techniques for brain tumor surgery: a systematic review. Frontiers in Oncology. 2025;14:1481430. doi:10.3389/fonc.2024.1481430

9. Casey SO, Sampaio RC, Michel E, et al. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol. 2000;21(7):1199-1206.

10. Radiology (ACR) RS of NA (RSNA) and AC of. Magnetic Resonance Imaging (MRI) - Head. Radiologyinfo.org. Accessed July 3, 2025. https://www.radiologyinfo.org/en/info/mri-brain

11. Brain MRI: What It Is, Purpose, Procedure & Results. Cleveland Clinic. Accessed July 1, 2025. https://my.clevelandclinic.org/health/diagnostics/22966-brain-mri

12. Gill A, Shellock FG. Assessment of MRI issues at 3-Tesla for metallic surgical implants: findings applied to 61 additional skin closure staples and vessel ligation clips. J Cardiovasc Magn Reson. 2012;14(1):3. doi:10.1186/1532-429X-14-3

13. Potential Hazards and Risks. UCSF Radiology. January 20, 2016. Accessed March 14, 2025. https://radiology.ucsf.edu/patient-care/patient-safety/mri/potential-hazards-risks

14. Costello JR, Kalb B, Martin DR. Incidence and Risk Factors for Gadolinium-Based Contrast Agent Immediate Reactions. Top Magn Reson Imaging. 2016;25(6):257-263. doi:10.1097/RMR.0000000000000109

15. McDonald RJ, McDonald JS, Kallmes DF, et al. Gadolinium Deposition in Human Brain Tissues after Contrast-enhanced MR Imaging in Adult Patients without Intracranial Abnormalities. Radiology. 2017;285(2):546-554. doi:10.1148/radiol.2017161595

16. Rowley PA, Paukner MJ, Eisenmenger LB, et al. Incidental Findings from 16,400 Brain MRI Examinations of Research Volunteers. American Journal of Neuroradiology. 2023;44(4). Accessed July 1, 2025. https://www.ajnr.org/content/early/2023/03/16/ajnr.A7821

17. Mall MA, Stahl M, Graeber SY, et al. Early detection and sensitive monitoring of CF lung disease: Prospects of improved and safer imaging. Pediatr Pulmonol. 2016;51(S44):S49-S60. doi:10.1002/ppul.23537

18. Tran D, Rahman Q, Weed M, et al. Differential diagnosis of a ring-enhancing brain lesion in the setting of metastatic cancer and a mycotic aneurysm. Radiol Case Rep. 2021;16(12):3850-3854. doi:10.1016/j.radcr.2021.09.041

19. Dmytriw AA, Sawlani V, Shankar J. Diffusion-Weighted Imaging of the Brain: Beyond Stroke. Canadian Association of Radiologists Journal. 2017;68(2):131-146. doi:10.1016/j.carj.2016.10.001

20. Rohilla S, Garg HK, Singh I, et al. rCBV- and ADC-based Grading of Meningiomas With Glimpse Into Emerging Molecular Diagnostics. Basic Clin Neurosci. 2018;9(6):417-428. doi:10.32598/bcn.9.6.417

21. Iancu-Gontard D, Oppenheim C, Touzé E, et al. Evaluation of Hyperintense Vessels on FLAIR MRI for the Diagnosis of Multiple Intracerebral Arterial Stenoses. Stroke. 2003;34(8):1886-1891. doi:10.1161/01.STR.0000080382.61984.FE

22. Doddamani RS, Meena RK, Sawarkar D. Ambiguity in the Dural Tail Sign on MRI. Surg Neurol Int. 2018;9:62. doi:10.4103/sni.sni_328_17

23. Wu Z, Mittal S, Kish K, et al. Identification of Calcification with Magnetic Resonance Imaging Using Susceptibility-Weighted Imaging: A Case Study. J Magn Reson Imaging. 2009;29(1):177-182. doi:10.1002/jmri.21617

24. Finneran M, Marotta DA, Altenburger D, et al. Long-term Survival in a Patient with Butterfly Glioblastoma: A Case Report. Cureus. 12(2):e6914. doi:10.7759/cureus.6914

25. Guo J, Yao C, Chen H, et al. The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas. Acta Neurochir (Wien). 2012;154(8):1361-1370. doi:10.1007/s00701-012-1418-x

26. MRI scan. NHS inform. Accessed July 3, 2025. https://www.nhsinform.scot/tests-and-treatments/scans-and-x-rays/mri-scan/

27. Iijima K, Hirato M, Miyagishima T, et al. Microrecording and image-guided stereotactic biopsy of deep-seated brain tumors. J Neurosurg. 2015;123(4):978-988. doi:10.3171/2014.10.JNS14963

28. Zimny A, Zińska L, Bladowska J, et al. Intracranial lesions with high signal intensity on T1-weighted MR images – review of pathologies. Pol J Radiol. 2013;78(4):36-46. doi:10.12659/PJR.889663

29. Villanueva-Meyer JE, Mabray MC, Cha S. Current Clinical Brain Tumor Imaging. Neurosurgery. 2017;81(3):397-415. doi:10.1093/neuros/nyx103

30. Wang M, Wang Z, Ren P, et al. Meningioma with ring enhancement on MRI: a rare case report. BMC Med Imaging. 2021;21:22. doi:10.1186/s12880-021-00555-x

31. Punpichet M, Limcharoenchai C, Suthiwartnaruput K, et al. Internal Cerebral Vein in Susceptibility-Weighted Imaging: A Reliable Tool to Differentiate Among Calcification, Microbleed, and Gross Hemorrhage in Brain Tumors. Cureus. 16(5):e61166. doi:10.7759/cureus.61166

32. Bydder GM, Rutherford MA, Hajnal JV. How to perform diffusion-weighted imaging. Childs Nerv Syst. 2001;17(4-5):195-201. doi:10.1007/s003810000281

33. Albano D, Micci G, Patti C, et al. Whole-Body Magnetic Resonance Imaging: Current Role in Patients with Lymphoma. Diagnostics (Basel). 2021;11(6):1007. doi:10.3390/diagnostics11061007

34. Guo J, Fu X, Li Y, et al. Ultra high b-value diffusion weighted imaging enables better molecular grading stratification over histological grading in adult-type diffuse glioma. Eur J Radiol. 2023;168:111140. doi:10.1016/j.ejrad.2023.111140

35. Kawaji H, Koizumi S, Sakai N, et al. Evaluation of tumor blood flow after feeder embolization in meningiomas by arterial spin-labeling perfusion magnetic resonance imaging. J Neuroradiol. 2013;40(4):303-306. doi:10.1016/j.neurad.2013.04.005

36. Zhao H, Wang HT. Magnetic resonance imaging scanning susceptibility weighted imaging sequences in the diagnosis and prognostic evaluation of neonatal hypoxic-ischemic encephalopathy. World J Clin Cases. 2024;12(17):3012-3018. doi:10.12998/wjcc.v12.i17.3012

37. Wright AM, Wu YC, Feng L, et al. Diffusion magnetic resonance imaging of cerebrospinal fluid dynamics: Current techniques and future advancements. NMR Biomed. 2024;37(9):e5162. doi:10.1002/nbm.5162

38. Rossmeisl JH, Clapp K, Pancotto TE, et al. Canine Butterfly Glioblastomas: A Neuroradiological Review. Front Vet Sci. 2016;3:40. doi:10.3389/fvets.2016.00040

39. Housni A, Boujraf S, Alami B, et al. Assessment of Primary Brain Lymphoma Using Multimodal Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy. Asian J Neurosurg. 2018;13(4):1205-1208. doi:10.4103/ajns.AJNS_137_17

40. Fink KR, Fink JR. Imaging of brain metastases. Surg Neurol Int. 2013;4(Suppl 4):S209-S219. doi:10.4103/2152-7806.111298

41. Luo X, Jiang H, Liu X, et al. Base MRI Imaging Characteristics of Meningioma Patients to Discuss the WHO Classification of Brain Invasion Otherwise Benign Meningiomas. Technol Cancer Res Treat. 2023;22:15330338231171470. doi:10.1177/15330338231171470

42. Zhang S, William C. Educational Case: Histologic and Molecular Features of Diffuse Gliomas. Acad Pathol. 2020;7:2374289520914021. doi:10.1177/2374289520914021

43. Kalode S, Banait S. Radiological and histopathological correlations in oligodendroglioma: a comprehensive case report. Pan Afr Med J. 2024;49:73. doi:10.11604/pamj.2024.49.73.45324

44. Opancina V, Esposito S, Di Meco F, et al. Magnetic resonance imaging characteristics of pediatric pilocytic astrocytoma. Neurol Sci. 2023;44(11):4033-4040. doi:10.1007/s10072-023-06893-8

45. Wagué D, Manneh EK, Sène F, et al. Brain abscess mimicking a brain tumor only realized during surgery: A case report in a resource strained environment. Surg Neurol Int. 2025;16:131. doi:10.25259/SNI_67_2025

46. Dubovoy AV, Jafarov VM, Voronina EI. Supratentorial dural-based collision of cavernoma and meningioma: a case report. Chin Neurosurg J. 2018;4:17. doi:10.1186/s41016-018-0128-5

47. Konar AS, Shah AD, Paudyal R, et al. Quantitative Relaxometry Metrics for Brain Metastases Compared to Normal Tissues: A Pilot MR Fingerprinting Study. Cancers (Basel). 2022;14(22):5606. doi:10.3390/cancers14225606

48. Watanabe H, Arai H, Ogihara K, et al. Diagnostic efficacy of contrast-enhanced fluid-attenuated inversion recovery (FLAIR) imaging in idiopathic cerebrospinal fluid rhinorrhea. Radiol Case Rep. 2024;19(10):4331-4334. doi:10.1016/j.radcr.2024.07.018

49. Raisi-Nafchi M, Faeghi F, Zali A, et al. Preoperative Grading of Astrocytic Supratentorial Brain Tumors with Diffusion-Weighted Magnetic Resonance Imaging and Apparent Diffusion Coefficient. Iran J Radiol. 2016;13(3):e30426. doi:10.5812/iranjradiol.30426

50. Scola E, Desideri I, Bianchi A, et al. Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study. Radiol Med. 2022;127(6):664-672. doi:10.1007/s11547-022-01470-z

51. Booth TC, Wiegers EC, Warnert EAH, et al. High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics. Frontiers in Oncology. 11(811425). doi:10.3389/fonc.2021.811425

52. Kokkinos V, Chatzisotiriou A, Seimenis I. Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging-Tractography in Resective Brain Surgery: Lesion Coverage Strategies and Patient Outcomes. Brain Sciences. 2023;13(11):1574. doi:10.3390/brainsci13111574

53. Wood J. Private MRI scan costs explained. Practice Plus Group. December 13, 2023. Accessed January 15, 2025. https://practiceplusgroup.com/knowledge-hub/private-mri-scan-costs-explained/